spacer
home > ict > autumn 2017 > cut off
PUBLICATIONS
International Clinical Trials

Cut off

A year ago in France, hardly anybody had heard of Emanuel
Macron, who has easily defeated the National Front’s Marine
Le Pen in the recent presidential election, and, at the time
of writing, looks to have founded a party that will win an
overwhelming majority in the French Parliament. Two months
ago, the UK’s Prime Minister, Theresa May, looked to be on
course for an equally overwhelming majority in the UK general
election, but is now hanging onto her position by the skin of
her teeth. These two rather contrasting outcomes have thrown
the UK’s Brexit strategy into sharp focus.

One of the major issues in the UK election was healthcare
and the concept of ‘our’ NHS. The UK spends, per capita,
significantly less on healthcare than many EU member states.
As a proportion of GDP, it will fall to 6.6%, compared to 7.3%
in 2014/15, whereas the EU average is 1.7% higher at 9.0%.
The government’s expenditure on R&D in the sector equally
falls below the average for the group of eight countries and is
at the bottom of the list.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

spacer
Dr Graham Hughes
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

BioIVT Acquires Cypex, a Leading Manufacturer of Drug-Metabolizing Enzymes

Westbury, NY – August 8, 2022 – BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today announced that it has acquired Cypex, a renowned manufacturer of recombinant xenobiotic metabolizing enzymes, based in Dundee, Scotland. Cypex’s extensive enzyme portfolio covers a wide range of proteins involved in drug metabolism.
More info >>

White Papers

Successfully managing the unique demands of cell therapy supply chains

PCI Pharma Services

Cell therapy professionals joined a specialist webinar by industry experts from PCI Clinical Services and TrakCel, addressing the unique complexity of an autologous therapy supply chain. Hosted by European Pharmaceutical Manufacturer magazine, the webinar was delivered by Rachel Griffiths, Associate Director, Technical Services, PCI Clinincal Services, and Dr. Matthew Lakelin, Vice President, Scientific Affairs and Business Development, TrakCel . Here, we present the white paper from that webinar event.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement